Priority 5 from the COPD Exacerbation PSP
|UNCERTAINTY: What are the associations between co-morbidity (other medical conditions) and risk of COPD exacerbations? (JLA PSP Priority 5)
|JLA question ID
|People living with COPD often have other medical conditions too. These are called 'co-morbidities'. This question seeks to better understand the relationship between co-morbidities and exacerbations. For example, is someone with anxiety and depression, or heart problems, likely to develop and/or experience exacerbations in a different way, that might lead to different outcomes or the need for different treatments?
This question is an area of uncertainty. https://www.ncbi.nlm.nih.gov/pubmed/20843247;
|Health Research Classification System category
|Extra information provided by this PSP
|Original uncertainty examples
Should we, and if so how can we reduce the risk of heart attack and stroke around the time of an exacerbation?~ Does dysphagia increase exacerbation risk? ~ Is there a role for SLT in preventing COPD exacerbations?~ Can controlling gastro-oesophageal reflux disease reduce the risk of copd exacerbation ~ does better management of cardiovascular disease reduce 'exacerbation' frequency
|Patient, Healthcare professional
|PSP unique ID
|COPD Exacerbation PSP
|Total number of uncertainties identified by this PSP.
|51 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
|Date of priority setting workshop
|1 April 2021